One good way Congress can bring down the cost of prescription medicines. by Ameet Sarpatwari and Aaron S Kesselheim Bloomberg In late April, Patrick Leahy, a Democratic senator, and Tom Marino, a Republican member of the House of Representatives, introduced legislation to promote timely access to low-cost, high-quality generic drugs. Passing this bipartisan CREATES Act…
Reckitt Benckiser Sued by 42 States for Abusive Practices LOS ANGELES, Calif. – (June 15, 2017) – Calling the national opioid epidemic a crisis requiring a comprehensive federal response, the Consumer Safety Coalition urged Congress and the Trump administration to set an example for misbehaving drug companies by using the market power of the federal…
Recent lawsuits are asking courts whether the current crisis is comparable to the one over tobacco in the ’90s. By Alana Samuels, The Atlantic Opioid abuse is rampant in states like Ohio, where paramedics are increasingly spending time responding to overdoses and where coroners’ offices are running out of room to store bodies. In 2012,…
Posted By Eric Sandy on Wed, May 31, 2017 Cleveland Scene Attorney General Mike DeWine targeted five pharmaceutical companies in a sweeping lawsuit filed today, alleging misrepresentation and misinformation on their part in the growing American opiate addiction crisis. The companies are Janssen Pharmaceutical, Allergan, Purdue Pharma, Endo and Cephalon. “They are the most prominent,”…
By Watchdog News / May 12, 2017 WISCONSIN – Suboxone, a medication that aids in the recovery of opiate addiction, will remain a preferred Medicaid-covered drug in Wisconsin despite complaints from state jail officials that it’s too easy to smuggle into prisons because of its film form. A state Medicaid pharmacy committee decided this week…
Reckitt Benckiser PLC (LON:RB.) first quarter numbers on Friday will still bear the scars of the scandal in South Korea that saw over 100 people die from a toxic humidifier sanitiser. But that isn’t the Cillit Bang and Dettol group’s only concern. Sales generally have been below par and its recent acquisition Mead Johnson has…